comprehensive
Previous article:
Drug repurposing or repositioning? The language matters
Next article: The lessons of Aduhelm, an Alzheimer's drug that was not to be
Next article: The lessons of Aduhelm, an Alzheimer's drug that was not to be
hotspot
focus
-
Woodcock on FDA’s accelerated approval and her next chapter
2025-09-30 00:48 -
Medicare drug price negotiation’s day in court
2025-09-29 22:33 -
Covid misinformation case heads to Supreme Court
2025-09-29 22:33 -
Readout Newsletter: What happened with Sarepta's Duchenne data
2025-09-29 22:32 -
Why Sanofi got shellacked over its spinoff
2025-09-29 22:19 -
The real point of Kenneth Smith’s execution by nitrogen gas
2025-09-29 22:11